NFIB and glioblastoma: Consistent with the xenograft survival data, we observed a reduction in cell proliferation in response to NFIB expression in both established and patient-derived mesenchymal (U87, U251 and WK1) and classical (RN1) GBM cell lines (Figure 4C).